However, GLS2 protein (p = 0.006), but not GLS, was predictive of a longer recurrence-free interval (Figure 7g,h), which remained independent of tumour size, grade and nodal stage (p = 0.003, Table 6). The gene discussed is GLS2; the disease is neoplasm.